Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains

International Journal of Antimicrobial Agents

Volumn 26, Issue 4, 2005, Pages 279-284

  Tomaso, Herbert ^a   Al Dahouk, Sascha ^a   Hofer, Erwin ^b   Splettstoesser, Wolf D ^a   Treu, Thomas M ^c   Dierich, Manfred P ^d   Neubauer, Heinrich ^a  

^a BUNDESWEHR INSTITUTE OF MICROBIOLOGY   (Germany)

^b AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

^c Institute for Medical Support Military Hospital Vienna   (Austria)

^d UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Antibiotic susceptibility; Biovar II; Francisella tularensis subsp. holarctica; MIC

Indexed keywords

AGAR; AMINOGLYCOSIDE; AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CYSTEINE; DOXYCYCLINE; GATIFLOXACIN; IMIPENEM; LEVOFLOXACIN; MACROLIDE; MEROPENEM; MOXIFLOXACIN; NORFLOXACIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; RIFAMPICIN; SPARFLOXACIN; STREPTOMYCIN; TETRACYCLINE; TOBRAMYCIN; UNINDEXED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRIA; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BIOTYPE; BLOOD; CLINICAL ARTICLE; COMPARATIVE STUDY; CORRELATION ANALYSIS; FRANCISELLA TULARENSIS; HARE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SHEEP;

AMINOGLYCOSIDES; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTITUBERCULAR; AUSTRIA; CARBAPENEMS; CEPHALOSPORINS; CHLORAMPHENICOL; FRANCISELLA TULARENSIS; HARES; HUMANS; MICROBIAL SENSITIVITY TESTS; QUINOLONES; RIFAMPIN; TETRACYCLINE; TULAREMIA;

EID: 25144439553     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.07.003     Document Type: Article

References (37)

1. R.I. Kudelina, and N.G. Olsufjev Sensitivity to macrolide antibiotics and lincomycin in Francisella holarctica J Hyg Epidemiol Microbiol Immunol 1 1980 84 91
2. N.G. Olsufiev, and I.S. Meshcheryakova Intraspecific taxonomy of tularemia agent Francisella tularensis McCoy et Chapin J Hyg Epidemiol Microbiol Immunol 20 1982 291 299
3. G. Sandstrom, A. Sjostedt, and M. Forsman Characterization and classification of strains of Francisella tularensis isolated in the central Asian focus of the Soviet Union and in Japan J Clin Microbiol 30 1992 172 175
4. J. Ellis, P.C. Oyston, and M. Green Tularemia Clin Microbiol Rev 15 2002 631 646
5. D.T. Dennis, T.V. Inglesby, and D.A. Henderson Working Group on Civilian Biodefense. Tularemia as a biological weapon: medical and public health management JAMA 285 2001 2763 2773
6. E. Hofer Epidemiologie, Klinik und mikrobiologische Diagnostik der Tularämie Antibiotika Monitor XVIII 1/2 2002 19 23
7. Z. Hubalek, W. Sixl, and J. Halouzka Prevalence of Francisella tularensis in Dermacentor reticulatus ticks collected in adjacent areas of the Czech and Austrian Republics Cent Eur J Public Health 5 1997 199 201
8. Z. Hubalek, W. Sixl, and J. Halouzka Francisella tularensis in Dermacentor reticulatus ticks from the Czech Republic and Austria Wien Klin Wochenschr 110 1998 909 910
9. A. Valipour, H. Koller, and A. Kreuzer A case of primary tularemic pneumonia presenting with necrotizing mediastinal and hilar lymph nodes Wien Klin Wochenschr 115 2003 196 199
10. V. Vyrostekova, G. Khanakah, and E. Kocianova Prevalence of coinfection with Francisella tularensis in reservoir animals of Borrelia burgdorferi sensu lato Wien Klin Wochenschr 114 2002 482 488
11. Hoeflechner-Poeltl A, Hofer E, Awad-Masalmeh M, et al. Tularaemie und Brucellose bei Feldhasen und Fuechsen in Oesterreich. Tierarztl Umsch 2000;55:263-8.
12. A. Deutz, K. Fuchs, and W. Schuller Seroepidemiological studies of zoonotic infections in hunters in southeastern Austria - prevalences, risk factors, and preventive methods Berl Munch Tierarztl Wochenschr 116 2003 306 311 [in German]
13. D. Gurycova, V. Vyrostekova, and G. Khanakah Importance of surveillance of tularemia natural foci in the known endemic area of Central Europe, 1991-1997 Wien Klin Wochenschr 113 2001 433 438
14. A. Tarnvik, H.S. Priebe, and R. Grunow Tularemia in Europe: an epidemiological overview Scand J Infect Dis 36 2004 350 355
15. J. Pikula, F. Treml, and M. Beklova Ecological conditions of natural foci of tularemia in the Czech Republic Eur J Epidemiol 18 2003 1091 1095
16. M.E. Evans, D.W. Gregory, and W. Schaffner Tularemia: a 30-year experience with 88 cases Medicine 64 1985 251 269
17. G. Enderlin, L. Morales, and R.F. Jacobs Streptomycin and alternative agents for the treatment of tularemia: review of the literature Clin Infect Dis 19 1994 42 47
18. O. Scheel, T. Hoel, and T. Sandvik Susceptibility pattern of Scandinavian Francisella tularensis isolates with regard to oral and parenteral antimicrobial agents APMIS 101 1993 33 36
19. H. Syrjala, R. Schildt, and S. Raisainen In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin Eur J Clin Microbiol Infect Dis 10 1991 68 70
20. C.N. Baker, D.G. Hollis, and C. Thornsberry Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth J Clin Microbiol 22 1985 212 215
21. N. García del Blanco, C.B. Gutierrez Martín, V.A. de la Puente Redondo, and E.F. Rodríguez Ferri In vitro susceptibility of field isolates of Francisella tularensis subsp. holarctica recovered in Spain to several antimicrobial agents Res Vet Sci 76 2004 195 198
22. S.D. Brown, K. Krisher, and M.M. Traczewski Broth microdilution susceptibility testing of Francisella tularensis: quality control limits for nine antimicrobial agents and three standard quality control strains J Clin Microbiol 42 2004 5877 5880
23. I. Ikäheimo, H. Syrjala, and J. Karhukorpi In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals J Antimicrob Chemother 46 2000 287 290
24. M. Maurin, N.F. Mersali, and D. Raoult Bactericidal activities of antibiotics against intracellular Francisella tularensis Antimicrob Agents Chemother 44 2000 3428 3431
25. H. Tomaso, E.C. Reisinger, and S. Al Dahouk Rapid detection of Yersinia pestis with multiplex real-time PCR assays using fluorescent hybridisation probes FEMS Immunol Med Microbiol 38 2003 117 126
26. A. Johansson, A. Ibrahim, and I. Goransson Evaluation of PCR-based methods for discrimination of Francisella species and subspecies and development of a specific PCR that distinguishes the two major subspecies of Francisella tularensis J Clin Microbiol 38 2000 4180 4185
27. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, Vol. 18, No. 1, M100-S8. Wayne, PA: NCCLS; 1998.
28. Deutsches Institut für Normung e.V. Susceptibility testing of pathogens to antimicrobial agents, part 4: evaluation classes of the minimum inhibitory concentration. Supplement 1: MIC breakpoints of antibacterial agents. Deutsches Institut für Normung document 58940-4. Berlin, Germany: Deutsches Institut für Normung e.V.; 1998.
29. Comité de l'Antibiogramme de la Société Française de Microbiologie Communiqué. Statement. Pathol Biol 1998;46:I-XVI.
30. Steineck T, Hofer E. Zum Vorkommen der Tularaemie in Oesterreich. 39 Internationales Symposium über die Erkrankungen der Zoo- und Wildtiere; 12-16 Mai 1999; Wien. Erkrankungen der Zootiere 1999;39:263-9.
31. E. Hofer, H. Schildorfer, and J. Flatscher Zum Nachweis der Tularaemie bei Feldhasen (Lepus europaeus) in Oesterreich Wien Tieraerztl Monatsschr 81 1997 301 308
32. W.D. Sawyer, H.G. Dangerfield, and A. Hogge Antibiotic prophylaxis and therapy of airborne tularemia Bacteriol Rev 30 1966 542 548
33. A. Johansson, L. Berglund, and L. Gothefors Ciprofloxacin for treatment of tularemia in children Pediatr Infect Dis J 19 2000 449 453
34. P. Russell, S.M. Eley, and M.J. Fulop The efficacy of ciprofloxacin and doxycycline against experimental tularemia J Antimicrob Chemother 41 1998 461 465
35. L.E. Markowitz, N.A. Hynes, and P. de la Cruz Tickborne tularemia: an outbreak of lymphadenopathy in children JAMA 254 1985 2922 2925
36. J.T. Cross, and R.F. Jacobs Tularemia: treatment failures with outpatient use of ceftriaxone Clin Infect Dis 17 1993 976 980
37. HPA-Colindale. Interim guidelines for action in the event of a deliberate release: tularemia, Version 1.2. London, UK: Health Protection Agency; 2003. http://www.hpa.org.uk/infections/topics_az/deliberate_release/Tularaemia/PDFs/ tularemia_guidelines.pdf [accessed 25 April 2005].